Drug
Botulinum Toxin Type B
Botulinum Toxin Type B: highest development phase Post-Market, developed by Supernus Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Supernus Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Botulinum Toxin Type B NCT00702754 | Post-Market | Cervical Dystonia |
Latest
No recent events.
Follow Botulinum Toxin Type B on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.